Cargando…
Sustained Increases in IGFBP-7 May Be Related to Doxorubicin in Breast Cancer Patients
Autores principales: | Wilcox, Nicholas S., Demessei, Biniyam G., Smith, Amanda M., Carver, Joseph R., Zhang, Liyong, Liu, Peter, Januzzi, James L., Ky, Bonnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463720/ https://www.ncbi.nlm.nih.gov/pubmed/34604806 http://dx.doi.org/10.1016/j.jaccao.2021.06.005 |
Ejemplares similares
-
Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
por: Thompson, Elizabeth W., et al.
Publicado: (2021) -
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020) -
Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity
por: Hoffman, Rebecca K., et al.
Publicado: (2021) -
Lifespan extension by increased expression of the Drosophila homologue of the IGFBP7 tumour suppressor
por: Alic, Nazif, et al.
Publicado: (2011) -
BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors
por: Demissei, Biniyam G., et al.
Publicado: (2022)